外染色体DNA作为癌症演变的动态引擎:结构,可塑性和治疗耐药性
Yan Gu1, Shuai Wang1, Yuxuan Xiao1
1Department of Thoracic Surgery, Peking University People's Hospital, Beijing 100044, China; Thoracic Oncology Institute, Peking University People's Hospital, Beijing 100044, China; Research Unit of Intelligence Diagnosis and Treatment in Early Non-small Cell Lung Cancer, Chinese Academy of Medical Sciences, 2021RU002, Peking University People's Hospital, Beijing 100044, China.
外染色体DNA (ecDNA) 通过基因放大和适应驱动癌症的进化. 了解ecDNA作为一个动态系统,揭示了癌症治疗的新治疗点.
科学领域:
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
背景情况:
- 异染色体DNA (ecDNA) 包含大型的圆形DNA分子,可以放大人类癌症中的瘤基因和调控元素.
- 埃克DNA的非门德尔分离和高的转录输出驱动瘤异质性,免疫逃避和治疗耐药性.
研究的目的:
- 审查目前对癌症中的ecDNA形成,维护和功能的理解.
- 将ecDNA呈现为一个动态的,可选择的基因组子系统,对癌症进化至关重要.
- 突出针对ecDNA的临床应用和治疗策略.
主要方法:
- 审查最近关于ecDNA形成,结构和功能的研究.
- 对多区域和纵向数据的分析,以了解ecDNA演变.
- 讨论ecDNA检测方法和治疗漏洞.
主要成果:
- EcDNA促进基因放大,增强器劫持和转录枢纽的形成.
- EcDNA架构定义了瘤内部和瘤之间并行的进化轨迹.
- 通过可逆拷贝数变化和途径重新连接,ecDNA有助于治疗耐药性.
结论:
- EcDNA是一个动态的基因组子系统,显著影响癌症的进化和进展.
- 了解ecDNA动态为改善患者分层和向治疗提供了机会.
- 利用ecDNA特定的漏洞为新型癌症治疗提供了一个有希望的途径.
更多相关视频
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
相关概念视频
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancers Originate from Somatic Mutations in a Single Cell
Treatment Resistant Cancers
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
